Bank of New York Mellon’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
Other funds holding CODX
PAG
SAM
SS
HWA
DB
Bank of New York Mellon's CODX Position: Q1 2026 in Review
Bank of New York Mellon sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 4,569 shares — an estimated $23.1K sold.
Bank of New York Mellon first reported a position in CODX in Q1 2020 and held it in 24 quarters. The position peaked at $1.92M in Q2 2020. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.
- Bank of New York Mellon reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
- Bank of New York Mellon sold 4,569 Co-Diagnostics shares in Q1 2026, an estimated $23.1K.
- Bank of New York Mellon first reported a position in Co-Diagnostics in Q1 2020 and held it in 24 quarters.
- Bank of New York Mellon's Co-Diagnostics position peaked at $1.92M in Q2 2020.
- 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.
Based on Bank of New York Mellon's 13F filing for Q1 2026, filed 5 May 2026.